Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Myelofibrosis
Related studies linked through entity extraction aliases.
A Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis
- Status
- COMPLETED
- Phase
- PHASE2
Quantitative MRI for Myelofibrosis
- Status
- RECRUITING
- Phase
- N/A
Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
- Status
- TERMINATED
- Phase
- NA
Identification of Mechanism in the Erythroid Response in Patients With Myelodysplasia Undergoing Chelation Therapy
- Status
- COMPLETED
- Phase
- N/A
Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
JAK2 Inhibitors RUXOLITINIB in Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis
- Status
- TERMINATED
- Phase
- PHASE2
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
- Status
- COMPLETED
- Phase
- NA
A Study to Find the Maximum Tolerated Dose of the Experimental Combination of the Drugs INC424 and BKM120 in Patients With Primary or Secondary Myelofibrosis
- Status
- TERMINATED
- Phase
- PHASE1
Sotatercept in Treating Patients With Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia
- Status
- COMPLETED
- Phase
- PHASE2
Panobinostat and Ruxolitinib In MyElofibrosis (PRIME Trial)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 2 Study in Japanese Patients With Intermediate-2 or High Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis With Splenomegaly
- Status
- COMPLETED
- Phase
- PHASE2
Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms
- Status
- COMPLETED
- Phase
- PHASE1
Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- NA
INC424 for Patients With Primary Myelofibrosis, Post Polycythemia Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis.
- Status
- COMPLETED
- Phase
- PHASE3
Clinical and Pathophysiological Investigations Into Erdheim Chester Disease
- Status
- COMPLETED
- Phase
- N/A